Literature DB >> 1398073

Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter.

Q Zhou1, P M Lieberman, T G Boyer, A J Berk.   

Abstract

Transcription factor IID (TFIID) binds to TATA boxes, nucleating the assembly of initiation complexes containing several general transcription factors and RNA polymerase II. Recently, TFIID was shown to be a multisubunit complex containing a TATA box-binding polypeptide (TBP) and several tightly associated polypeptides (TAFs), which are required for transcriptional stimulation by activator proteins. Here, we report the development of a human cell line expressing an epitope-tagged TBP and the immunopurification of a native, high-molecular-weight form of TFIID that supports transcriptional stimulation by several different classes of activation domains. Recovery of basal and activated TFIID transcriptional specific activity was close to approximately 100%. Electrophoretic mobility-shift analysis demonstrated a single major DNA-protein complex. This holo-TFIID contains TAFs of approximately 250, 125, 95, 78, and 50 kD and sediments at 17S. Holo-TFIID produced an extended footprint over the adenovirus major late promoter TATA box and initiator sequence and supported transcriptional activation from a promoter lacking a TATA box. These results lead us to hypothesize that a single multisubunit TFIID protein supports transcriptional stimulation by diverse activation domains and from a TATA-less promoter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398073     DOI: 10.1101/gad.6.10.1964

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  174 in total

1.  The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter.

Authors:  T C Kuhlman; H Cho; D Reinberg; N Hernandez
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.

Authors:  M E Martin; A J Berk
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Developmental regulation of transcription by a tissue-specific TAF homolog.

Authors:  M A Hiller; T Y Lin; C Wood; M T Fuller
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

4.  Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA.

Authors:  B Grondin; N DeLuca
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger.

Authors:  Y G Gangloff; J C Pointud; S Thuault; L Carré; C Romier; S Muratoglu; M Brand; L Tora; J L Couderc; I Davidson
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates.

Authors:  Zheng Chen; James L Manley
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA.

Authors:  Kristina M Johnson; Jin Wang; Andrea Smallwood; Charina Arayata; Michael Carey
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

Review 8.  Multi-protein complexes in eukaryotic gene transcription.

Authors:  Ernest Martinez
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

9.  Differential cellular requirements for activation of herpes simplex virus type 1 early (tk) and late (gC) promoters by ICP4.

Authors:  Susan Zabierowski; Neal A DeLuca
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.

Authors:  B Gu; N DeLuca
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.